Vicapsys Life Sciences, Inc. (VICP)
1.45
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Vicapsys Life Sciences Cash and Short Term Investments (Quarterly) : 0.1325M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1325M |
| March 31, 2025 | 0.0059M |
| December 31, 2024 | 0.0116M |
| September 30, 2024 | 0.0896M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.0094M |
| September 30, 2023 | 0.0535M |
| June 30, 2023 | 0.2313M |
| March 31, 2023 | 0.0041M |
| December 31, 2022 | 0.0141M |
| September 30, 2022 | 0.0262M |
| June 30, 2022 | 0.0173M |
| March 31, 2022 | 0.1013M |
| December 31, 2021 | 0.2173M |
| September 30, 2021 | 0.1655M |
| June 30, 2021 | 0.1706M |
| March 31, 2021 | 0.0305M |
| December 31, 2020 | 0.0013M |
| September 30, 2020 | 0.0017M |
| June 30, 2020 | 0.005M |
| March 31, 2020 | 0.0309M |
| December 31, 2019 | 0.2642M |
| September 30, 2019 | |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | 0.0863M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.69M |